Page last updated: 2024-11-05

thalidomide and Pus

thalidomide has been researched along with Pus in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rúa-Figueroa, I1
Erausquin, C1
Naranjo, A1
Carretero-Hernández, G1
Rodriguez-Lozano, C1
De la Rosa, P1

Other Studies

1 other study available for thalidomide and Pus

ArticleYear
Pustuloderma during cutaneous lupus treatment with thalidomide.
    Lupus, 1999, Volume: 8, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Drug Eruptions; Female; Humans;

1999